Stay updated on Pembrolizumab + Radiation in SCCHN Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.

Latest updates to the Pembrolizumab + Radiation in SCCHN Clinical Trial page
- Check3 days agoChange DetectedRevision indicator updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Show glossary option and new metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. Removed 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange Detected- Revision: v3.3.4 added and Revision: v3.3.3 removed are administrative/versioning updates and do not modify study content. - There is no impact on the study details, eligibility criteria, outcomes, or other core information. - To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check46 days agoChange DetectedLocations section updated; Maryland, North Carolina, and Pennsylvania sites added and the HHS Vulnerability Disclosure link removed as part of revision 3.3.3.SummaryDifference0.4%

- Check74 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed and may not all pertain to the study. The revision version has been updated to v3.3.2.SummaryDifference0.1%

- Check81 days agoChange DetectedRemoved the banner about government funding lapses and potential delays in updates; the page's study details remain unchanged.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab + Radiation in SCCHN Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Radiation in SCCHN Clinical Trial page.